Fundamental company data provided by Morningstar and Zacks Investment Research. MarketBeat's community ratings are surveys of what our community members think about Health Catalyst and other stocks. Do Not Sell My Information. Health Catalyst General Information Description. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. A high-level overview of Health Catalyst, Inc. (HCAT) stock. The company has a current ratio of 7.91, a quick ratio of 7.91 and a debt-to-equity ratio of 0.70. Its solution comprises a cloud-based data platform, analytics software, and professional services expertise. Get short term trading ideas from the MarketBeat Idea Engine. The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says... Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. All rights reserved. 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. Know More. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The firm's revenue for the quarter was up 19.8% on a year-over-year basis. Their average twelve-month price target is $40.40, predicting that the stock has a possible upside of 15.40%. View all competitors. Change Volume Today's Open Previous Close. Vote “Outperform” if you believe HCAT will outperform the S&P 500 over the long term. Real time Health Catalyst Inc (HCAT) stock price quote, stock graph, news & analysis. The high price target for HCAT is $44.00 and the low price target for HCAT is $36.00. Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Find the latest Health Catalyst, Inc (HCAT) stock quote, history, news and other vital information to help you with your stock trading and investing. Health Catalyst has a market capitalization of $1.56 billion and generates $154.94 million in revenue each year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. (Add your “outperform” vote. MarketBeat just released five new trading ideas, but Health Catalyst wasn't one of them. Salt Lake City, UT- October 29, 2020- Health Catalyst, Inc. ('Health Catalyst,' Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year strategic partnership with Middle East Healthcare Company (MEAHCO) to service six Saudi German Hospitals in the Kingdom of Saudi Arabia (KSA). (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. Since then, HCAT shares have increased by 33.3% and is now trading at $36.76. The company was founded in 2008 and is headquartered in Salt Lake City, Utah. Health Catalyst is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021. There are currently 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Health Catalyst's stock was trading at $27.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Learn more. The company issued revenue guidance of $50.5-53.5 million, compared to the consensus revenue estimate of $47.44 million. The P/E ratio of Health Catalyst is -16.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Top institutional investors include Wells Fargo & Company MN (6.11%), BlackRock Inc. (5.60%), Victory Capital Management Inc. (2.99%), Riverbridge Partners LLC (2.48%), Norwest Venture Partners XI LP (2.21%) and Point72 Asset Management L.P. (1.91%). 81.45% of the stock of Health Catalyst is held by institutions. To see all exchange delays and terms of use please see disclaimer. Stock Information Stock Information Stock Quote. The company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.06. Health Catalyst to Participate in Upcoming Investor Conference. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Health Catalyst had a negative net margin of 48.17% and a negative return on equity of 25.57%. Vote “Underperform” if you believe HCAT will underperform the S&P 500 over the long term. In the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. HCAT: Get the latest Health Catalyst stock price and detailed information including HCAT news, historical charts and realtime prices. Please log in to your account or sign up in order to add this asset to your watchlist. HCAT stock was sold by a variety of institutional investors in the last quarter, including Norwest Venture Partners XI LP, Point72 Asset Management L.P., Massachusetts Financial Services Co. MA, Morgan Stanley, Perceptive Advisors LLC, Cubist Systematic Strategies LLC, Allianz Asset Management GmbH, and Nepsis Inc.. Company insiders that have sold Health Catalyst company stock in the last year include Anita Pramoda, D Fraser Bullock, Dale Sanders, Daniel D Burton, Daniel H Orenstein, James Patrick Jr Nelli, Linda Llewelyn, Paul Horstmeier, and Timothy G Ferris. * Guggenheim Digital Health Virtual Conference which will include a fireside chat presentation on Tuesday, December 8, 2020 at 3:15 p.m. EST, as well as one-on-one meetings on Wednesday, December 9, 2020. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Health Catalyst's stock is owned by many different retail and institutional investors. According to analysts' consensus price target of $40.40, Health Catalyst has a forecasted upside of 9.7% from its current price of $36.84. Health Catalyst's stock was trading at $27.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Get daily stock ideas top-performing Wall Street analysts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View which stocks are hot on social media with MarketBeat's trending stocks report. Subscribe to Premium to view Fair Value for HCAT. Its solutions include a cloud-based data platform, analytics software, and professional services. It has two operating segments. Export data to Excel for your own analysis. Health Catalyst envisions a future in which all healthcare decisions are data informed.Health Catalyst Investor Relations Contact:Adam Brown Senior Vice President, Investor Relations and FP&A +1 (855)-309-6800 ir@healthcatalyst.comHealth Catalyst Media Contact:Kristen Berry Vice President, Public Relations +1 (617) 234-4123 +1 (774) 573-0455 (m) kberry@we-worldwide.com, These 4 Measures Indicate That Anaconda Mining (TSE:ANX) Is Using Debt Reasonably Well. Learn everything you need to know about successful options trading with this three-part video course. An audio-only recording will be available at https://ir.healthcatalyst.com/investor-relations. * Evercore ISI HealthCONx Conference on Thursday, December 3, 2020, which will include a fireside chat presentation at 4:20 p.m. EST. Health Catalyst has received 78 “outperform” votes. Since then, HCAT shares have increased by 19.7% and is now trading at $33.00. View our earnings forecast for Health Catalyst. Health Catalyst shares (HCAT) are listed on the NASDAQ and all prices are listed in US Dollars. Some companies that are related to Health Catalyst include Medallia (MDLA), HUYA (HUYA), DouYu International (DOYU), TripAdvisor (TRIP), Switch (SWCH), Sabre (SABR), Rackspace Technology (RXT), Cardlytics (CDLX), 21Vianet Group (VNET), SVMK (SVMK), Pluralsight (PS), Magnite (MGNI), Yalla Group (YALA), Internet Initiative Japan (IIJIY) and Eventbrite (EB). Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. After-Hours earnings guidance on Tuesday, November, 10th. Shares of Health Catalyst stock opened at $34.48 on Thursday. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 All rights reserved. Want to see which stocks are moving? During the same period in the prior year, the business posted ($0.27) earnings per share. At this point, Health Catalyst stock is 21% below its 52-week high of $41.26, underperforming the S&P 500 with a 1.7% decline this year. Business Description. The company's average rating score is 3.11, and is based on 8 buy ratings, no hold ratings, and no sell ratings. HCAT, Health Catalyst Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Only 22.10% of the stock of Health Catalyst is held by insiders. Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT.". SALT LAKE CITY, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and … The company can be reached via phone at 801-708-6800 or via email at [email protected]. The company earns $-60,100,000.00 in net income (profit) each year or ($1.42) on an earnings per share basis. View insider buying and selling activity for Health Catalyst. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Specifically, they have bought $0.00 in company stock and sold $4,333,830.00 in company stock. ), Health Catalyst has received 53 “underperform” votes. Wall Street analysts have given Health Catalyst a "Buy" rating, but there may be better short-term opportunities in the market. Health Catalyst does not currently pay a dividend. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View the latest Health Catalyst Inc. (HCAT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Looking for new stock ideas? Health Catalyst Reports Third Quarter 2020 Results. HCAT stock was bought by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Riverbridge Partners LLC, BlackRock Inc., Ashford Capital Management Inc., Karani Asset Management LLC, Charles Schwab Investment Management Inc., Victory Capital Management Inc., and Morse Asset Management Inc. View insider buying and selling activity for Health Catalyst. Don’t Give up on Twitter (NYSE: TWTR) Stock, 3 Cannabis Stocks For The Budding Rebound, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Receive Analysts' Upgrades and Downgrades Daily. Health Catalyst, Inc. (NASDAQ:HCAT) released its quarterly earnings data on Sunday, November, 15th. Learn more. Health Catalyst's mailing address is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. The stock’s fifty day moving average price is $35.32 and its 200-day moving average price is $31.67. Get today's Health Catalyst Inc stock price and latest HCAT news as well as Health Catalyst real-time stock quotes, technical analysis, full financials and more. Health Catalyst has a P/B Ratio of 5.23. Health Catalyst has received 59.54% “outperform” votes from our community. Company insiders that own Health Catalyst stock include Anita Pramoda, D Fraser Bullock, Dale Sanders, Daniel D Burton, Daniel H Orenstein, James Patrick Jr Nelli, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris. View analysts' price targets for Health Catalyst. Today's High Today's Low 52 Week High 52 Week Low. Health Catalyst has received a consensus rating of Buy. On average, they expect Health Catalyst's share price to reach $40.40 in the next year. 9 equities research analysts have issued 1-year price objectives for Health Catalyst's stock. High institutional ownership can be a signal of strong market trust in this company. View real-time stock prices and stock quotes for a full financial overview. Health Catalyst, Inc is a health information services business based in the US. How to buy shares in Health Catalyst. Health Catalyst does not have a long track record of dividend growth. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, committed to being the catalyst for massive, … It has two operating segments. In depth view into HCAT (Health Catalyst) stock including the latest price, news, dividend history, earnings information and financials. Stock Chart. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View analyst ratings for Health Catalyst or view MarketBeat's top 5 stock picks. Health Catalyst employs 1,000 workers across the globe. You may vote once every thirty days. SALT LAKE CITY, Oct. 22, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced today the appointment of Amanda Hundt to the newly created position of Vice President of Corporate Communications. Health Catalyst employs 900 staff and has a trailing 12-month revenue of around USD$171.3 million. Health Catalyst has only been the subject of 4 research reports in the past 90 days. Learn about financial terms, types of investments, trading strategies and more. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. © 2020 Verizon Media. Health Catalyst's management team includes the following people: Chief Communications and Diversity, Equity & Inclusion Officer, Start Your Risk-Free Trial Subscription Here, Ozon Holdings (NASDAQ:OZON) Stock: What to Know About the Amazon of Russia, iRobot (NASDAQ: IRBT) Stock providing a Holiday Pullback Opportunity, Five Below (NASDAQ:FIVE) Rises To New Highs But Wait To Buy It, Turbo Boost for Carvana (NYSE:CVNA) As Jefferies Starts Coverage, Another Big Opportunity In Deep-Value Big Lots (NYSE:BIG), Zumiez (NASDAQ:ZUMZ) Zooms To New All-Time High. View institutional ownership trends for Health Catalyst. See what's happening in the market right now with MarketBeat's real-time news feed. Health Catalyst (HCAT) delivered earnings and revenue surprises of 22.22% and 5.69%, respectively, for the quarter ended September 2020. © American Consumer News, LLC dba MarketBeat® 2010-2020. Shares of HCAT can be purchased through any online brokerage account. Identify stocks that meet your criteria using seven unique stock screeners. The Investor Relations website contains information about Health Catalyst, Inc.'s business for stockholders, potential investors, and financial analysts. HCAT | Complete Health Catalyst Inc. stock news by MarketWatch. (Add your “underperform” vote.). Sign-up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Why Is Wall Street So Excited About Asana (NYSE: ASAN)? Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Get the latest Health Catalyst, Inc. HCAT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Get the latest Health Catalyst, Inc (HCAT) stock news and headlines to help you in your trading and investing decisions. View our full suite of financial calendars and market data tables, all for free. Health Catalyst updated its fourth quarter 2020 Receive a free world-class investing education from MarketBeat. SALT LAKE CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, President, Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences: * Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020, which will include a fireside chat presentation. The official website for Health Catalyst is www.healthcatalyst.com. The business earned $47.20 million during the quarter, compared to analysts' expectations of $44.59 million. Health Catalyst Inc () Stock Market info Recommendations: Buy or sell Health Catalyst stock? Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Compare share trading platforms. About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. The company provided EPS guidance of for the period. View Health Catalyst, Inc. HCAT investment & stock information. 9 Wall Street analysts have issued ratings and price targets for Health Catalyst in the last 12 months. Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. Stock analysis for Health Catalyst Inc (HCAT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. Does PagerDuty (NYSE:PD) Have A Healthy Balance Sheet? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Earnings for Health Catalyst are expected to grow in the coming year, from ($1.56) to ($1.27) per share. View which stocks have been most impacted by COVID-19. Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Get detailed information on Health Catalyst stock (NASDAQ: HCAT), including today’s stock quote, real-time price, financial history, charts, and more. Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), salesforce.com (CRM), Alteryx (AYX), The Walt Disney (DIS), DocuSign (DOCU), Square (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology Group (MRVL) and PayPal (PYPL). This suggests a possible upside of 9.9% from the stock's current price. View Health Catalyst's earnings history. Their forecasts range from $36.00 to $44.00. One share of HCAT stock can currently be purchased for approximately $36.76.